{"id":"ergot","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Paresthesias","drugRate":"","severity":"common","organSystem":""},{"effect":"Numbness","drugRate":"","severity":"common","organSystem":""},{"effect":"Weakness","drugRate":"","severity":"common","organSystem":""},{"effect":"Vertigo","drugRate":"","severity":"common","organSystem":""},{"effect":"Localized edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Itching","drugRate":"","severity":"common","organSystem":""},{"effect":"Transient tachycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Transient bradycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Hypertension","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Achalasia of esophagus","Acute exacerbation of asthma","Acute nephropathy","Agoraphobia","Alcoholism","Anemia","Angle-closure glaucoma","Atony of colon","Autonomic dysreflexia","Bacterial septicemia","Benign prostatic hyperplasia","Bladder outflow obstruction","Bleeding","Brain damage","Breastfeeding (mother)","Cardiovascular event risk","Cerebral ischemia","Chronic heart failure","Chronic lung disease","Chronic obstructive lung disease","Complete trisomy 21 syndrome","Conduction disorder of the heart","Depressive disorder","Diarrhea","Disease of liver","Disorder of coronary artery","Disturbance of salivary secretion","Drowsy","Drug AND/OR toxin-induced diarrhea","Dyspnea","Ergot Alkaloid Toxicity","Fibrosis of lung","Fibrosis of pleura","Gastric ulcer","Gastrointestinal obstruction","Hepatic coma","Hepatic encephalopathy","Hepatic failure","Hiatal hernia","Hyperactive behavior","Hyperammonemia","Hypertensive disorder","Hypertensive urgency","Hyperthyroidism","Impaired renal function disorder","Insomnia","Kidney disease","Myasthenia gravis","Myocardial dysfunction","Myocardial infarction in recovery phase","Myocardial ischemia","Necrotizing enterocolitis in fetus OR newborn","Neutropenic disorder","Obsessive-compulsive disorder","Panic disorder","Paralytic ileus","Peptic reflux disease","Peptic ulcer","Peripheral ischemia","Peripheral vascular disease","Poisoning by phenobarbital","Porphyria","Pregnancy, function","Prinzmetal angina","Pyloric obstruction","Raynaud's phenomenon","Respiratory insufficiency","Retention of urine","Retroperitoneal fibrosis","Seizure disorder","Sepsis syndrome","Severe Pruritus","Severe chronic ulcerative colitis","Sleep apnea","Sleep automatism","Spastic paralysis","Substance abuse","Suicidal thoughts","Tachyarrhythmia","Thrombocytopenic disorder","Thrombophlebitis","Toxic megacolon","Ulcerative colitis","Urinary tract obstruction","Vascular surgery procedure"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Gangrene","drugRate":"","severity":"serious"},{"effect":"Ischemia","drugRate":"","severity":"serious"},{"effect":"Cyanosis","drugRate":"","severity":"serious"},{"effect":"Absence of pulse","drugRate":"","severity":"serious"},{"effect":"Cold extremities","drugRate":"","severity":"serious"},{"effect":"Precordial distress and pain","drugRate":"","severity":"serious"},{"effect":"EKG changes","drugRate":"","severity":"serious"},{"effect":"Muscle pains","drugRate":"","severity":"serious"},{"effect":"Fibrotic complications","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["ergonovine maleate"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Ergot","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:23:53.593627+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:23:59.156522+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ergot","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:23:59.491571+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL442/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:24:00.219014+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"4db7eece-2eef-bc1b-e063-6394a90a98cb","title":"CAFERGOT (ERGOTAMINE TARTRATE AND CAFFEINE) TABLET, FILM COATED [TRIFLUENT PHARMA, LLC]"},"ecosystem":[],"mechanism":{"target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6"},"_scrapedAt":"2026-03-28T04:37:17.846Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:24:01.917369+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Cluster Headache Prevention","diseaseId":"cluster-headache-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Cluster headache syndrome","diseaseId":"cluster-headache-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Migraine","diseaseId":"migraine","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vascular headache","diseaseId":"vascular-headache","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07492160","phase":"PHASE2","title":"Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2026-03-16","conditions":"Pregnancy, Abortion","enrollment":348},{"nctId":"NCT07490405","phase":"NA","title":"Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism","status":"NOT_YET_RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-04-01","conditions":"Liver Cirrhosis","enrollment":140},{"nctId":"NCT07226362","phase":"PHASE1","title":"A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults","status":"COMPLETED","sponsor":"Aspeya Switzerland SA","startDate":"2025-06-09","conditions":"Safety, and Tolerability","enrollment":44},{"nctId":"NCT07463235","phase":"PHASE3","title":"Safety and Potency of a High Cabergoline Dosage in Microprolactinomas","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-03-04","conditions":"Prolactinoma, Prolactin Excess","enrollment":70},{"nctId":"NCT07043322","phase":"PHASE2","title":"Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-06-30","conditions":"Gynecologic Disease","enrollment":150},{"nctId":"NCT07309471","phase":"NA","title":"Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-03-06","conditions":"LSD Reaction","enrollment":24},{"nctId":"NCT05551182","phase":"PHASE3","title":"Nicergoline Use in Dysphagia Patients","status":"COMPLETED","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2023-01-01","conditions":"Dysphagia","enrollment":92},{"nctId":"NCT07390864","phase":"NA","title":"Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-01-18","conditions":"Myoma;Uterus","enrollment":40},{"nctId":"NCT07386080","phase":"PHASE4","title":"Carbergoline for Antipsychotic Induced Hyperprolactinemia.","status":"NOT_YET_RECRUITING","sponsor":"Zealand University Hospital","startDate":"2026-05-01","conditions":"Scizophrenia","enrollment":146},{"nctId":"NCT03928288","phase":"PHASE2","title":"Cabergoline for the Treatment of Chronic Pain Due to Endometriosis","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2019-12-02","conditions":"Endometriosis","enrollment":129},{"nctId":"NCT07318467","phase":"NA","title":"Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-01-01","conditions":"Post Partum Hemorrhage","enrollment":80},{"nctId":"NCT07255911","phase":"NA","title":"Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-02-07","conditions":"PCOS","enrollment":72},{"nctId":"NCT06909123","phase":"PHASE2","title":"A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-07","conditions":"Lactation Suppressed","enrollment":36},{"nctId":"NCT06018025","phase":"","title":"NDPH Biomarker Study in Children and Adolescents","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-04-15","conditions":"New Persistent Daily Headache","enrollment":38},{"nctId":"NCT03525002","phase":"PHASE2","title":"Dopamine Action on Metabolism in Relation to Genotype","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2018-05-03","conditions":"Obesity","enrollment":120},{"nctId":"NCT07072910","phase":"PHASE2","title":"Cabergoline for Episodic Migraine","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-12","conditions":"Migraine","enrollment":150},{"nctId":"NCT07008417","phase":"PHASE1","title":"A Study on Bioequivalence of Cabergoline Tablets in Human Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-06-30","conditions":"Hyperprolactinemia","enrollment":72},{"nctId":"NCT05964647","phase":"PHASE1","title":"Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-02-01","conditions":"Healthy","enrollment":20},{"nctId":"NCT03584854","phase":"PHASE4","title":"Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-03-01","conditions":"Postpartum Hemorrhage, Uterine Atony","enrollment":100},{"nctId":"NCT06029673","phase":"PHASE2","title":"Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss","status":"COMPLETED","sponsor":"Stanford University","startDate":"2024-02-07","conditions":"Lactation Suppressed","enrollment":69},{"nctId":"NCT07164287","phase":"","title":"Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Geneva","startDate":"2020-06-01","conditions":"Major Depressive Disorder (MDD), Anxiety Disorders, Substance Use Disorder (SUD)","enrollment":376},{"nctId":"NCT07124221","phase":"PHASE3","title":"A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-09-12","conditions":"Hyperprolactinemia","enrollment":382},{"nctId":"NCT07189299","phase":"NA","title":"Microdosing LSD in Women With Premenstrual Disorders","status":"NOT_YET_RECRUITING","sponsor":"Friederike Holze","startDate":"2025-10-01","conditions":"PMS, PMDD","enrollment":150},{"nctId":"NCT07045935","phase":"PHASE4","title":"Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-09-16","conditions":"Prolactinoma","enrollment":60},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT03575000","phase":"PHASE4","title":"Bromocriptine for Patients With Schizophrenia and Prediabetes","status":"NOT_YET_RECRUITING","sponsor":"VA Pittsburgh Healthcare System","startDate":"2026-01-01","conditions":"Schizophrenia, PreDiabetes","enrollment":15},{"nctId":"NCT07168837","phase":"NA","title":"Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-01-10","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":100},{"nctId":"NCT07166835","phase":"NA","title":"Exploring the Cognitive Benefits of a Blackcurrant-Based Supplement in Normobaric Hypoxia","status":"NOT_YET_RECRUITING","sponsor":"Leeds Beckett University","startDate":"2025-09-01","conditions":"Cognitive Performance, Executive Function (Cognition), Working Memory","enrollment":27},{"nctId":"NCT04413344","phase":"PHASE1, PHASE2","title":"Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease","status":"COMPLETED","sponsor":"Kyoto University","startDate":"2020-06-05","conditions":"Familial Alzheimer Disease (FAD), PSEN1 Mutation","enrollment":8},{"nctId":"NCT05883540","phase":"PHASE2","title":"Lysergic Acid Diethylamide (LSD) in Palliative Care","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-06-09","conditions":"Palliative Care, Pain, Anxiety","enrollment":60},{"nctId":"NCT07061886","phase":"EARLY_PHASE1","title":"Drug Effects on Mood and Behavior - Expectancy","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-06-26","conditions":"LSD","enrollment":48},{"nctId":"NCT07017478","phase":"EARLY_PHASE1","title":"Mood Effects of Serotonin Agonists: Depression","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-06-09","conditions":"LSD, Major Depressive Disorder, Depression","enrollment":48},{"nctId":"NCT07034859","phase":"PHASE4","title":"Cabergoline in the Management of Nonfunctioning Pituitary Adenoma","status":"ENROLLING_BY_INVITATION","sponsor":"National Taiwan University Hospital","startDate":"2024-05-20","conditions":"Pituitary Adenoma, MRI, RCT","enrollment":30},{"nctId":"NCT05772156","phase":"PHASE4","title":"Prophylactic Methylergonovine for Twin Cesarean","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-03-07","conditions":"Twin; Complicating Pregnancy, Postpartum Hemorrhage","enrollment":66},{"nctId":"NCT02288962","phase":"PHASE3","title":"Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2014-11","conditions":"Pituitary Neoplasms, Adenoma","enrollment":60},{"nctId":"NCT06557239","phase":"","title":"Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy","status":"COMPLETED","sponsor":"Tatiana Aboulafia Brakha","startDate":"2024-08-05","conditions":"Depression, Anxiety","enrollment":10},{"nctId":"NCT03866252","phase":"PHASE2","title":"LSD Therapy for Persons Suffering From Major Depression","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-11-01","conditions":"Major Depressive Disorder","enrollment":60},{"nctId":"NCT05477459","phase":"PHASE2","title":"LSD to Improve Cluster Headache Impact Trial","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-04-16","conditions":"Chronic Cluster Headache","enrollment":65},{"nctId":"NCT05570708","phase":"NA","title":"The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training","status":"ENROLLING_BY_INVITATION","sponsor":"Felix Mueller","startDate":"2022-10-25","conditions":"Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD","enrollment":48},{"nctId":"NCT04128683","phase":"EARLY_PHASE1","title":"Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2020-10-20","conditions":"Anorexia Nervosa","enrollment":31},{"nctId":"NCT05177419","phase":"PHASE1","title":"Effects of LSD on Neuroplasticity in Healthy Subjects","status":"COMPLETED","sponsor":"University of Fribourg","startDate":"2022-05-02","conditions":"Healthy","enrollment":45},{"nctId":"NCT06899334","phase":"PHASE1","title":"Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-04-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT05976698","phase":"NA","title":"LSD-Perceptual-Choice-Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-02-26","conditions":"LSD Reaction","enrollment":30},{"nctId":"NCT06285409","phase":"NA","title":"Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2024-04-04","conditions":"Postpartum Hemorrhage","enrollment":32},{"nctId":"NCT03781128","phase":"PHASE2","title":"Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-01-02","conditions":"Cluster Headache","enrollment":30},{"nctId":"NCT06333691","phase":"NA","title":"Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin","status":"COMPLETED","sponsor":"Minia University","startDate":"2022-10-01","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":180},{"nctId":"NCT05953038","phase":"EARLY_PHASE1","title":"LSD Occupancy of the Serotonin 2A Receptor in the Human Brain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2023-11-08","conditions":"Basic Science","enrollment":40},{"nctId":"NCT06250257","phase":"PHASE3","title":"Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age","status":"RECRUITING","sponsor":"Jimma University","startDate":"2024-10-21","conditions":"Dilated Cardiomyopathy","enrollment":112},{"nctId":"NCT06689644","phase":"NA","title":"Effect of a Plant Based Nootropic on Perceptual Decision Making.","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2023-10-23","conditions":"Cognitive Enhancement","enrollment":37},{"nctId":"NCT01794793","phase":"PHASE4","title":"Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies","status":"COMPLETED","sponsor":"RECORDATI GROUP","startDate":"2013-06-10","conditions":"Cushing's Disease, Acromegaly, Neuroendocrine Tumors","enrollment":337},{"nctId":"NCT05030129","phase":"PHASE2","title":"ERG/5-HTP in Fragile X Syndrome (FXS)","status":"COMPLETED","sponsor":"Elizabeth Berry-Kravis","startDate":"2021-10-07","conditions":"Fragile X Syndrome","enrollment":15},{"nctId":"NCT06560814","phase":"PHASE2","title":"Non-surgical Interventions for Infertility in Endometriosis","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2020-07-01","conditions":"Endometriosis, Infertility, Female","enrollment":18},{"nctId":"NCT06556186","phase":"NA","title":"Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-10-01","conditions":"Pituitary Tumor","enrollment":600},{"nctId":"NCT06123026","phase":"PHASE4","title":"Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-12-18","conditions":"Lactation Suppressed, Second Trimester Abortion","enrollment":200},{"nctId":"NCT00650520","phase":"PHASE1","title":"Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2007-05","conditions":"Healthy","enrollment":119},{"nctId":"NCT00649168","phase":"PHASE1","title":"Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2007-04","conditions":"Healthy","enrollment":120},{"nctId":"NCT05175430","phase":"PHASE1","title":"Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-10-24","conditions":"Healthy","enrollment":24},{"nctId":"NCT05525611","phase":"NA","title":"Cabergoline as a Preventive Treatment for Chronic Migraine","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2022-09-05","conditions":"Migraine","enrollment":36},{"nctId":"NCT04865653","phase":"PHASE1","title":"LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-03-17","conditions":"Healthy","enrollment":20},{"nctId":"NCT04701333","phase":"PHASE2","title":"Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-04-01","conditions":"Lactation Suppressed","enrollment":73},{"nctId":"NCT04227756","phase":"PHASE1","title":"Comparative Acute Effects of LSD, Psilocybin and Mescaline","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-05-19","conditions":"Healthy","enrollment":32},{"nctId":"NCT03790358","phase":"PHASE1","title":"Mood Effects of Serotonin Agonists","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-05-01","conditions":"Healthy","enrollment":80},{"nctId":"NCT03934710","phase":"PHASE1","title":"Mood Effects of Serotonin Agonists Extended","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2019-04-20","conditions":"Healthy","enrollment":56},{"nctId":"NCT04940390","phase":"PHASE3","title":"A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine","status":"COMPLETED","sponsor":"Satsuma Pharmaceuticals, Inc.","startDate":"2021-06-30","conditions":"Migraine, Migraine With Aura, Migraine Without Aura","enrollment":1591},{"nctId":"NCT05474989","phase":"PHASE2","title":"LSD Treatment for Persons With Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Felix Mueller","startDate":"2024-06-01","conditions":"Alcohol Use Disorder (AUD)","enrollment":126},{"nctId":"NCT06035913","phase":"","title":"Mid-and Long-term Efficacy of Ergot Alkaloids in the Treatment of Salivation in Patients With Parkinson's Disease.","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-09-01","conditions":"Main Heading (Descriptor) Terms","enrollment":80},{"nctId":"NCT04674670","phase":"NA","title":"Psychobiological Mechanisms Underlying Chronic Pain","status":"COMPLETED","sponsor":"susanne becker","startDate":"2021-11-01","conditions":"Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread","enrollment":48},{"nctId":"NCT05981742","phase":"PHASE2","title":"Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS","status":"COMPLETED","sponsor":"Al-Rasheed University College","startDate":"2022-09-21","conditions":"Polycystic Ovary Syndrome","enrollment":75},{"nctId":"NCT00920387","phase":"PHASE2","title":"Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety","status":"COMPLETED","sponsor":"Multidisciplinary Association for Psychedelic Studies","startDate":"2008-02","conditions":"Anxiety","enrollment":12},{"nctId":"NCT04406649","phase":"PHASE3","title":"A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine","status":"COMPLETED","sponsor":"Satsuma Pharmaceuticals, Inc.","startDate":"2020-09-14","conditions":"Migraine, Migraine With Aura, Migraine Without Aura","enrollment":482},{"nctId":"NCT03901482","phase":"PHASE3","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine","status":"COMPLETED","sponsor":"Satsuma Pharmaceuticals, Inc.","startDate":"2019-06-24","conditions":"Migraine, Migraine With Aura, Migraine Without Aura","enrollment":1201},{"nctId":"NCT04262024","phase":"PHASE1","title":"Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2020-02-01","conditions":"Health Education","enrollment":120},{"nctId":"NCT02590601","phase":"PHASE3","title":"Bromocriptine in the Treatment of Peripartum Cardiomyopathy","status":"WITHDRAWN","sponsor":"Montreal Heart Institute","startDate":"2017-01-01","conditions":"Peripartum Cardiomyopathy","enrollment":""},{"nctId":"NCT05674669","phase":"PHASE1","title":"A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy Volunteers","status":"COMPLETED","sponsor":"Eleusis Therapeutics","startDate":"2015-10-20","conditions":"Healthy","enrollment":32},{"nctId":"NCT05670184","phase":"PHASE1, PHASE2","title":"The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality","status":"UNKNOWN","sponsor":"Maastricht University","startDate":"2023-01-01","conditions":"Prosocial Behavior","enrollment":60},{"nctId":"NCT05351086","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults","status":"COMPLETED","sponsor":"Pulmatrix Inc.","startDate":"2022-06-09","conditions":"Healthy","enrollment":26},{"nctId":"NCT03390010","phase":"PHASE1","title":"Misoprostol Versus Active Management of Labour in CS","status":"COMPLETED","sponsor":"Aljazeera Hospital","startDate":"2017-12-28","conditions":"Cesarean Section","enrollment":300},{"nctId":"NCT05024422","phase":"NA","title":"Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2021-12-31","conditions":"Lactation Suppressed","enrollment":89},{"nctId":"NCT05565976","phase":"PHASE2, PHASE3","title":"Dapagliflozin Effect in Cognitive Impairment in Stroke Trial","status":"UNKNOWN","sponsor":"Jaime Daniel Mondragon","startDate":"2020-08-01","conditions":"Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular","enrollment":270},{"nctId":"NCT05405244","phase":"PHASE3","title":"Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-09-19","conditions":"Overweight and Obesity, Eating Behavior","enrollment":55},{"nctId":"NCT04516902","phase":"PHASE1","title":"Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-01-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT03904446","phase":"PHASE4","title":"Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients","status":"COMPLETED","sponsor":"Cynthia Wong","startDate":"2019-06-08","conditions":"Uterine Atony With Hemorrhage","enrollment":160},{"nctId":"NCT05337254","phase":"PHASE1","title":"A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects","status":"COMPLETED","sponsor":"Satsuma Pharmaceuticals, Inc.","startDate":"2021-03-05","conditions":"Migraine, Migraine With Aura, Migraine Without Aura","enrollment":36},{"nctId":"NCT00335777","phase":"PHASE4","title":"A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2006-08","conditions":"Migraine","enrollment":64},{"nctId":"NCT03153579","phase":"PHASE2","title":"LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-06-23","conditions":"Patients, Anxiety Disorders","enrollment":46},{"nctId":"NCT02682901","phase":"PHASE4","title":"Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2015-10-05","conditions":"Diabetic Autonomic Neuropathy","enrollment":84},{"nctId":"NCT02929485","phase":"PHASE4","title":"Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor","status":"WITHDRAWN","sponsor":"University of California, Berkeley","startDate":"2013-07","conditions":"Addiction","enrollment":""},{"nctId":"NCT04558294","phase":"PHASE1","title":"Effect of Ketanserin After LSD Administration","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-10-16","conditions":"Healthy","enrollment":24},{"nctId":"NCT03885154","phase":"PHASE2","title":"Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine","status":"TERMINATED","sponsor":"Kimberly S Jones","startDate":"2017-10-03","conditions":"Migraine in Children","enrollment":24},{"nctId":"NCT02544321","phase":"PHASE2","title":"Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-09","conditions":"Type 1 Diabetes","enrollment":108},{"nctId":"NCT03496545","phase":"PHASE1, PHASE2","title":"Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2018-11-30","conditions":"Subarachnoid Hemorrhage, Subdural Hematoma, Traumatic Brain Injury","enrollment":47},{"nctId":"NCT04096027","phase":"PHASE4","title":"Cabergoline Before or After Oocyte Collection for Follicular Resolution","status":"COMPLETED","sponsor":"Fertility Center of Las Vegas","startDate":"2019-09-23","conditions":"Infertility, Female","enrollment":70},{"nctId":"NCT03604744","phase":"EARLY_PHASE1","title":"Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-03-27","conditions":"Healthy","enrollment":28},{"nctId":"NCT03557333","phase":"PHASE3","title":"Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)","status":"COMPLETED","sponsor":"Impel Pharmaceuticals","startDate":"2018-07-13","conditions":"Migraine Headache","enrollment":360},{"nctId":"NCT01869556","phase":"NA","title":"Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2013-06-04","conditions":"Postpartum Hemorrhage","enrollment":105},{"nctId":"NCT01915303","phase":"PHASE2","title":"Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-03-06","conditions":"Cushings Disease","enrollment":68},{"nctId":"NCT00998556","phase":"PHASE2","title":"Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2010-06","conditions":"Peripartum Cardiomyopathy","enrollment":64},{"nctId":"NCT03578263","phase":"NA","title":"Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-04-01","conditions":"Cesarean Section Complications","enrollment":220},{"nctId":"NCT03303235","phase":"EARLY_PHASE1","title":"Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2020-07","conditions":"Uterine Atony, Uterine Tone Disorders, Postpartum Hemorrhage","enrollment":""},{"nctId":"NCT04421105","phase":"PHASE1","title":"A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years","status":"COMPLETED","sponsor":"Eleusis Therapeutics","startDate":"2015-06-29","conditions":"Healthy Volunteers","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL442"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":4997,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Ergot","genericName":"Ergot","companyName":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","companyId":"samuel-lunenfeld-research-institute-mount-sinai-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:24:01.917369+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}